Editorial portrait. Not a photograph of HPA treatment or a before-and-after comparison.
01 / THE DOCUMENTED EVENTS
What is on the public record.
After upper-arm liposuction, Tamao Sato reported severe swelling and declined to take part in the planned advertising for the treatment. Her former agency sought damages, including for the cancelled advertising. The Tokyo District Court dismissed its claims in 2015.
A treatment decision and a favourable endorsement can become so closely linked that an unwanted outcome affects both clinical care and production.
03 / WHERE HPA COULD HELP
Where thoughtful care could make a contribution.
Independent assessment, recovery time and a second expert opinion would be relevant before treatment. If an unwanted outcome occurs, the HPA framework provides for assessing urgency and further care needs. An advertising obligation must not displace necessary care. It would not be possible to claim retrospectively that a particular complication could have been prevented.
These publicly documented cases illustrate different risks: contract disputes, conflicting advertising claims, interrupted care and later negative associations with a brand. The people and companies are editorial case studies; their inclusion does not imply that HPA has cared for them. Each HPA perspective is a hypothetical application of our proposed services, not evidence that HPA could have prevented the events described.
These editorial portraits identify the people discussed. They may have been taken at a different time from the events in the case study. We draw no clinical findings or conclusions about treatment needs from their appearance.
